APA

Eron J. J., Young B., Cooper D. A., Youle M., Dejesus E., Andrade-Villanueva J., Workman C., Zajdenverg R., Fätkenheuer G., Berger D. S., Kumar P. N., Rodgers A. J., Shaughnessy M. A., Walker M. L., Barnard R. J. O., Miller M. D., Dinubile M. J., Nguyen B., Leavitt R., Xu X. & Sklar P. (20100218). Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials. : Lancet (London, England).

Chicago

Eron Joseph J, Young Benjamin, Cooper David A, Youle Michael, Dejesus Edwin, Andrade-Villanueva Jaime, Workman Cassy, Zajdenverg Roberto, Fätkenheuer Gerd, Berger Daniel S, Kumar Princy N, Rodgers Anthony J, Shaughnessy Melissa A, Walker Monica L, Barnard Richard J O, Miller Michael D, Dinubile Mark J, Nguyen Bach-Yen, Leavitt Randi, Xu Xia and Sklar Peter. 20100218. Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials. : Lancet (London, England).

Harvard

Eron J. J., Young B., Cooper D. A., Youle M., Dejesus E., Andrade-Villanueva J., Workman C., Zajdenverg R., Fätkenheuer G., Berger D. S., Kumar P. N., Rodgers A. J., Shaughnessy M. A., Walker M. L., Barnard R. J. O., Miller M. D., Dinubile M. J., Nguyen B., Leavitt R., Xu X. and Sklar P. (20100218). Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials. : Lancet (London, England).

MLA

Eron Joseph J, Young Benjamin, Cooper David A, Youle Michael, Dejesus Edwin, Andrade-Villanueva Jaime, Workman Cassy, Zajdenverg Roberto, Fätkenheuer Gerd, Berger Daniel S, Kumar Princy N, Rodgers Anthony J, Shaughnessy Melissa A, Walker Monica L, Barnard Richard J O, Miller Michael D, Dinubile Mark J, Nguyen Bach-Yen, Leavitt Randi, Xu Xia and Sklar Peter. Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials. : Lancet (London, England). 20100218.